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Esophageal adenocarcinoma is a rare--but increasingly common--cancer with a high mortality 
rate.  While risk factors such as gastroesophageal reflux, cigarette smoking, obesity, and Heliobacter 
pylori CagA seronegativity play a role in the majority of cases, the genetic contributions to 
esophageal adenocarcinoma risk have not yet been fully identified.  Finding these genetic factors is 
an important step towards identifying those at highest risk in order to more precisely target 
prevention, surveillance, and treatment efforts.  Collaborating with an international team of 
colleagues, Dr. Thomas Vaughan in the Public Health Sciences Division recently published two high 
profile papers that help to elucidate the genetic underpinnings of this commonly fatal 
disease.  Together, these findings demonstrate that many shared genes underlie the development of 
both esophageal adenocarcinoma and its main precursor, Barrett’s esophagus. 
The first paper, in the Journal of the National Cancer Institute, evaluated the genetic architecture 
underlying gastroesophageal reflux, Barrett’s esophagus, and esophageal adenocarcinoma.  These 
three conditions were expected to share some common genetic background, as Barrett’s esophagus 
typically arises in patients with chronic gastroesophageal reflux, and each year up to 0.5% of 
Barrett’s esophagus cases progress to esophageal adenocarcinoma.  Utilizing genome-wide 
association data, the authors found that 25% of esophageal adenocarcinoma cases, and 35% of 
Barrett’s esophagus cases, were influenced by common genetic variants.  They also found a high 
genetic correlation and a statistically significant polygenic overlap between these two conditions, but 
not with gastroesophageal reflux.  These results suggested that shared genetic variation underlies 
the development of Barrett’s esophagus and esophageal adenocarcinoma. 
This finding proved a useful insight for the second paper, in Nature Genetics, in which the authors 
combined cases of both conditions together to perform a joint genome-wide association study on 
Barrett’s esophagus and esophageal adenocarcinoma.  Using this combined case group the authors 
were able to identify three new genetic loci associated with risk of these diseases, as well as extend 
one previously reported association with Barrett’s esophagus to esophageal 
adenocarcinoma.  Together with the findings from their JNCI study, says Vaughan, these results 
suggest that "the role of inherited susceptibility to this cancer appears to be much stronger in the 
early stages of the disease".  In other words, much of the genetic basis for this cancer seems to lie in 
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"the development of Barrett’s esophagus, rather than in the progression of Barrett’s to esophageal 
adenocarcinoma".  
This hypothesis is buoyed by the fact that all four loci identified (CRTC1, BARX1, FOXP1, and 
FOXF1) are in or near genes associated with early development of the esophagus or oncogenic 
activity.  The identification of such loci, says Vaughan, "implies that we may be close to finding some 
important pathways in the development of this highly fatal disease".  
Both projects leveraged the collective resources of BEACON, the Barrett’s and Esophageal 
Adenocarcinoma Consortium, combining scientific resources and expertise from institutions in North 
America, Europe, and Australia.  This collaborative effort was key to both projects, says Dr. 
Vaughan, which "wouldn’t have taken place without the generosity and trust of the participating 
scientists".  Combining forces provided the authors the number of cases and controls necessary to 
study these conditions together, and the ability to explore multiple hypotheses simultaneously.  To 
this end, the authors already have over a dozen additional analyses underway, including projects to 
examine gene-environment interactions, investigate disease pathways involving multiple gene sets, 
and characterize overlap with somatic genomic changes.  Given their recent success in elucidating 
the genetic underpinnings of these conditions, such follow-up certainly seems warranted. 
Other PHS investigators contributing to this project were Drs. Lynn Onstad and Brian Reid. 
Ek WE, Levine DM, D’Amato M, Pedersen NL, Magnusson PKE, Bresso F, Onstad LE, Schmidt PT, 
Tornblom H, Nordenstedt H, Romero Y (on behalf of the Mayo Clinic Esophageal Adenocarcinoma 
and Barrett’s Esophagus Registry Consortium), Chow W, Murray LJ, Gammon MD, Liu G, Bernstein 
L, Casson AG, Risch HA, Shaheen NJ, Bird NC, Reid BJ, Corley DA, Hardie LJ, Ye W, Wu AH, 
Zucchelli M, Spector TD, Hysi P, Vaughan TL, Whiteman DC, MacGregor S, on behalf of the 
BEACON study investigators. 2013. Germline genetic contributions to risk for esophageal 
adenocarcinoma, Barrett’s esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 
105(22):1711-8. 
Levine DM, Weronica EE, Zhang R, Liu X, Onstad L, Sather C, Lao-Sirieix P, Gammon MD, Corley 
DA, Shaheen NJ, Bird NC, Hardie LJ, Murray LJ, Reid BJ, Chow W, Risch HA, Nyren O, Ye W, Liu 
G, Romero Y, Bernstein L, Wu AH, Casson AG, Chanock SJ, Harrington P, Caldas I, Debiram-
Beecham I, Caldas C, Hayward NK, Pharoah PD, Fitzgerald RC, MacGregor S, Whiteman DC, 
Vaughan TL. 2013. A genome-wide association study identifies new susceptibility loci for 
esophageal adenocarcinoma and Barrett’s esophagus. Nat Genet. 45(12):1487-93. 
 
December 16, 2013 SCIENCE SPOTLIGHT 
 





Image provided by Dr. Thomas Vaughan. 
Regional association plot for the newly identified 
association of the CRTC1 gene with Barrett's esophagus 
and esophageal adenocarcinoma. The x-axis refers to 
genomic position, while the y-axis denotes the –log(10) p-
value of the association between each single nucleotide 
polymorphism (SNP) in the region and the combined 
Barrett’s esophagus and esophageal adenocarcinoma. The 
SNPs are color-coded according to linkage disequilibrium 
with the top finding, rs10419226. 
 
